The Place of Radiofrequency Ablation in the Multimodal Treatment of Cervical Cancer. Our Experience
M.A. Marincaş, V.M. Prunoiu, S. Ionescu, E. BrătucuOriginal article, no. 2, 2014
Introduction: Genital cancers benefit from standardized treatmentplans which include: surgery and radio chemotherapy.Lately, treatments involving thermal ablations have enteredthe clinical use, as they destroy the tumors by the use ofdifferent energy sources. Our study aims at establishing aprecise role of RFA in current treatment protocols of cancerof the uterine cervix.Material and method: We performed a 5-year (2008-2013)prospective study in which we analyzed the use of RFA inpatients treated for cancer of the uterine cervix at our clinic.RFA was used, on selective criteria, in bleeding tumors of theuterine cervix in patients with acute secondary anaemia(Hb=7-11g dl). The results revealed the haemostatic role ofthe method, RFA being the only non surgical method throughwhich one can achieve quick haemostasis (20 min.). 61patients were clinically observed, with ages between 39 and73, and the number of procedures performed was 61.Conclusion: RFA is useful in the treatment of cancers of theuterine cervix, in all stages of the disease, and it achieves quickhaemostasis. RFA can be considered an additional treatmentoption in neoadjuvant tumor palliation. The method can beassociated with surgery and radio chemotherapy. Its assets arelow specific morbidity (1,6%) and mortality (0%). We consider that RFA is on its way to an important place inoncology treatment protocols.
